Intech Investment Management LLC Buys 4,138 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Intech Investment Management LLC boosted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 92.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,612 shares of the medical instruments supplier’s stock after buying an additional 4,138 shares during the period. Intech Investment Management LLC’s holdings in ICU Medical were worth $1,336,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atria Investments Inc bought a new stake in shares of ICU Medical in the 3rd quarter worth $228,000. CIBC Asset Management Inc increased its holdings in shares of ICU Medical by 9.8% in the 3rd quarter. CIBC Asset Management Inc now owns 2,262 shares of the medical instruments supplier’s stock worth $412,000 after purchasing an additional 201 shares in the last quarter. Mutual of America Capital Management LLC increased its holdings in shares of ICU Medical by 9.2% in the 3rd quarter. Mutual of America Capital Management LLC now owns 3,673 shares of the medical instruments supplier’s stock worth $669,000 after purchasing an additional 308 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of ICU Medical by 12.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 19,181 shares of the medical instruments supplier’s stock worth $3,495,000 after purchasing an additional 2,190 shares in the last quarter. Finally, Swiss National Bank increased its holdings in shares of ICU Medical by 5.6% in the 3rd quarter. Swiss National Bank now owns 45,219 shares of the medical instruments supplier’s stock worth $8,240,000 after purchasing an additional 2,400 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

NASDAQ:ICUI opened at $147.07 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The business’s 50-day simple moving average is $156.08 and its two-hundred day simple moving average is $164.40. The stock has a market cap of $3.61 billion, a PE ratio of -32.18 and a beta of 0.73. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26.

Wall Street Analyst Weigh In

ICUI has been the topic of a number of research reports. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research note on Wednesday, December 11th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Raymond James set a $97.00 target price on ICU Medical in a research report on Wednesday, March 12th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $168.67.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.